COVID-19 AND ERYTHEMA MULTIFORME: CLINICAL CONTEXT

COVID-19 AND ERYTHEMA MULTIFORME: CLINICAL CONTEXT

Authors

  • KHATUNA KUDAVA
  • RUSUDAN LATSABIDZE

DOI:

https://doi.org/10.52340/jecm.2022.06.017

Abstract

Cutaneous manifestations of COVID-19 play an essential role in the diagnosis and assessment of the course of the disease. The conducted studies provide important information about skin rashes in patients of different ages suffering from coronavirus. Some studies describe the appearance of an erythema multiforme-like rash in patients with COVID-19. We consider the link between COVID-19 and erythema multiforme in a clinical context. We present two interesting cases. The first case refers to a 19-year-old woman with a history of idiopathic recurrent multiform erythema, with periodic exacerbations. The second patient of interest to us was a 22-year-old 14-week pregnant woman. The patient had a history of atopic dermatitis. In the first case, the Covid-19 infection was not found to be a provoking factor for the exacerbation of erythema multiforme. The patient's skin showed a common pathology associated with this infection, acral purpuric lesions. In the second case, COVID-19 was the reason for infection and development of an erythema multiforme-like rash. Consideration in a clinical context of Covid-19 infection and erythema multiforme is important and requires further detailed study.

Downloads

Download data is not yet available.

References

Giulia Daneshgaran, Danielle P Dubin, Daniel J Gould. Cutaneous Manifestations of COVID-19: An Evidence-Based Review; Am J Clin Dermatol 2020; 21(5):627-639.

Michael Gottlieb, Brit Long. Dermatologic manifestations and complications of COVID-19. Am J Emerg Med 2020; 38(9):1715-1721.

Uwe Wollina, Ayşe Serap Karadağ, Christopher Rowland-Payne, Anca Chiriac, Torello Lotti. Cutaneous signs in COVID-19 patients: A review. Dermatol Ther 2020; 33(5): e13549.

Harjas Singh, Harleen Kaur, Kanhaiya Singh, Chandan K Sen. Cutaneous Manifestations of COVID-19: A Systematic Review. Adv Wound Care (New Rochelle) 2021; 10(2):51-80.

Genovese G, Moltrasio C, Berti E, Marzano AV. Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives. Dermatology. 2021; 237(1):1-12.

Luigi Bennardo, Steven Paul Nisticò, Stefano Dastoli, Eugenio Provenzano, Maddalena Napolitano, Martina Silvestri, Maria Passante, Cataldo Patruno. Erythema Multiforme and COVID-19: What Do We Know? Medicina (Kaunas) 2021; 16; 57(8):828.

Olayemi Sokumbi, David A Wetter. Clinical features, diagnosis, and treatment of erythema multiforme: a review for the practicing dermatologist. Int J Dermatol 2012; 51(8):889-902.

Kathryn P Trayes, Gillian Love, James S Studdiford. Erythema Multiforme: Recognition and Management. Review Am Fam Physician 2019; 15; 100(2):82-88.

Marianne Lerch, Carlo Mainetti, Benedetta Terziroli Beretta-Piccoli, Thomas Harr. Current Perspectives on Erythema Multiforme. Review Clin Rev Allergy Immunol. 2018; 54(1):177-184.

Natasha Favoretto Dias de Oliveira, Denise Miyamoto, Celina Wakisaka Maruta, Valeria Aoki, Claudia Giuli Santi. Recurrent erythema multiforme: A therapeutic proposal for a chronic disease. J Dermatol 2021; 48(10):1569-1573.

Downloads

Published

2022-09-06

How to Cite

KUDAVA, K. ., & LATSABIDZE, R. . (2022). COVID-19 AND ERYTHEMA MULTIFORME: CLINICAL CONTEXT. Experimental and Clinical Medicine Georgia, (6). https://doi.org/10.52340/jecm.2022.06.017

Issue

Section

Articles
Loading...